1.52

2.70% 0.04

After Hours: 1.53 0.01 +0.66%

Inmune Bio Inc (INMB)

Overview News Price History Option Chain Financials Discussions Forecast

Inmune Bio Inc stock is traded at $1.52, with a volume of 253.10K. It is up +2.70% in the last 24 hours and down -20.00% over the past month. INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Previous Close:

$1.48

Open:

$1.48

24h Volume:

253.10K

Relative Volume:

0.49

Market Cap:

$40.41M

Revenue:

$155.00K

Net Income/Loss:

$-30.01M

P/E Ratio:

-0.9102

EPS:

-1.67

Net Cash Flow:

$-11.98M

1W Performance:

+1.33%

1M Performance:

-20.00%

6M Performance:

-79.18%

1Y Performance:

-68.33%

1-Day Range:

$1.46

$1.53

1-Week Range:

$1.4499

$1.62

52-Week Range:

$1.38

$11.64

Inmune Bio Inc Stock (INMB) Company Profile

Name

Inmune Bio Inc

Sector

Healthcare (1134)

Industry

Biotechnology (635)

Phone

(858) 964-3720

Address

225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA

Employee

Twitter

@INmuneBio

Next Earnings Date

2025-08-01

Latest SEC Filings

INMB's Discussions on Twitter

Compare INMB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INMB Inmune Bio Inc	1.52	39.35M	155.00K	-30.01M	-11.98M	-1.67
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Inmune Bio Inc Stock (INMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-01-25	Downgrade	BTIG Research	Buy → Neutral
Jul-01-25	Downgrade	Scotiabank	Sector Outperform → Sector Underperform
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Oct-21-24	Initiated	Alliance Global Partners	Buy
Sep-27-24	Initiated	Raymond James	Outperform
Aug-22-24	Initiated	Scotiabank	Sector Outperform
Jun-01-23	Initiated	Robert W. Baird	Outperform
May-24-22	Downgrade	B. Riley Securities	Buy → Neutral
Jul-07-21	Reiterated	Maxim Group	Buy
Apr-21-21	Initiated	B. Riley Securities	Buy
Jan-22-21	Reiterated	Maxim Group	Buy
Sep-01-20	Initiated	BTIG Research	Buy
Jul-15-20	Reiterated	H.C. Wainwright	Buy

View All

Inmune Bio Inc Stock (INMB) Latest News

Nov 23, 2025

INmune Bio Inc Stock Analysis and ForecastStock Buy Signals & Minimal Capital Appreciation - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Is INmune Bio Inc. stock positioned for long term growth2025 Technical Overview & Technical Buy Zone Confirmation - newser.com

Nov 21, 2025

Nov 19, 2025

Analyzing recovery setups for INmune Bio Inc. investorsMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com

Nov 19, 2025

Is INmune Bio Inc. a candidate for recovery playWeekly Gains Report & Consistent Profit Alerts - newser.com

Nov 19, 2025

Why INmune Bio Inc. stock is a value investor pickRisk Management & Daily Entry Point Alerts - newser.com

Nov 19, 2025

Heatmap analysis for INmune Bio Inc. and competitorsWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com

Nov 19, 2025

Short interest data insights for INmune Bio Inc.Market Trend Review & Verified Technical Signals - newser.com

Nov 19, 2025

How INmune Bio Inc. stock benefits from global expansionMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com

Nov 19, 2025

Nov 18, 2025

Candlestick signals on INmune Bio Inc. stock today2025 Momentum Check & Expert Curated Trade Ideas - newser.com

Nov 18, 2025

INmune Bio (INMB) Stock Analysis Report | Financials & Insights - Benzinga

Nov 18, 2025